Why XERS? Xeris Biopharma Holdings, Inc. Analysis, Price & AI Insights | Whystock
XERS
$6.28+0.15 (+2.53%)
Market ClosedLast close May 1
Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois.